233
Views
4
CrossRef citations to date
0
Altmetric
Original Scientific Papers

Prevalence and predictors of left atrial thrombosis in atrial fibrillation patients treated with non-vitamin K antagonist oral anticoagulants

ORCID Icon, , , , ORCID Icon, , , , ORCID Icon, & show all
Pages 290-297 | Received 24 Jun 2021, Accepted 06 Nov 2021, Published online: 25 Nov 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Patrizio Lancellotti & Caroline Piette. (2023) Special issue on atrial fibrillation. Acta Cardiologica 78:3, pages 269-273.
Read now
Selda Murat, Bektas Murat & Bulent Gorenek. (2023) Predictors of left atrial thrombosis in atrial fibrillation patients treated with direct oral anticoagulants. Acta Cardiologica 78:3, pages 371-371.
Read now

Articles from other publishers (2)

Josip Katic & Josip Andelo Borovac. (2023) Treatment of Persistent Left Atrial Appendage Thrombus in Patients with Atrial Fibrillation on Adequate Oral Anticoagulation: Pathways of Care for All-comers and Heart Failure Patients. Cardiac Failure Review 9.
Crossref
Shaobo Shi, Qingyan Zhao, Tao Liu, Shujuan Zhang, Jinjun Liang, Yanhong Tang, Bo Yang, He Huang & Congxin Huang. (2022) Left Atrial Thrombus in Patients With Non-valvular Atrial Fibrillation: A Cross-Sectional Study in China. Frontiers in Cardiovascular Medicine 9.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.